Project Grant K01DA062902
- Federal Grant Award Summary The University of Pittsburgh received a $488,334 Project Grant award from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning September 30, 2025, with an ultimate completion date of August 31, 2027. The PROMOTE study (Personalized Methadone Treatment by Implementing Shared Decision Making) will adapt and test implementation facilitation strategies to support systematic shared decision-making (SDM)...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a Mentored Research Scientist Development Award (K01) totaling $399,600 under the Drug Use and Addiction Research Programs (CFDA 93.279) to support a five-year career development and mentored research initiative. Awarded on August 15, 2025, with completion targeted for July 31, 2030, this grant funds Dr. Jason Brian Gibbons at the University of Colorado Anschutz Medical Campus to develop machine learning-based...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $194,903 Project Grant to the University of Pennsylvania on April 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) funding mechanism. This five-year research project, extending through March 31, 2030, supports Dr. Ashish Thakrar's research on methadone loading dose initiation for hospitalized patients with opioid use disorder (OUD) related to fentanyl use. The project addresses a...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of South Carolina a Project Grant of $192,149 under the Drug Use and Addiction Research Programs (CFDA 93.279) for the period February 1, 2026, through January 31, 2028. This research project investigates the noradrenergic mechanisms underlying stress-induced opioid reinstatement, specifically examining how stress exposure triggers increased cytokine release and heightened activity in the locus...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Johns Hopkins University a Project Grant totaling $182,187 under the Drug Use and Addiction Research Programs (CFDA 93.279) effective August 1, 2025 through July 31, 2030. This research initiative will advance understanding of spatial access to medications for opioid use disorder (MOUD), such as buprenorphine and methadone, with co-located mental health services across multiple U.S. cities. The research will...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Trustees of Columbia University in the City of New York a Project Grant of $193,644 under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a multilevel epidemiological study examining polysubstance use trajectories and overdose risk prediction. Beginning September 1, 2025, and extending through August 31, 2030, this award supports research leveraging the National Longitudinal Study of...
- Federal Grant Award Summary The University of Pittsburgh received a $188,995 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded August 15, 2025, with a completion date of July 31, 2028. The "Prescribe to Prevent HIV" (P2PH) trial will develop and pilot test an implementation strategy bundle designed to increase access to two evidence-based harm reduction interventions—sterile injection equipment and daily...
- Federal Project Grant Award Summary Boston University received a $193,751 Career Development Award from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning May 1, 2026 and concluding April 30, 2031. This grant supports the development of an independent researcher focused on improving substance use disorder (SUD) services through a rigorous training and research program. The primary deliverables include research examining variation in...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $197,500 Project Grant to the University of California, San Diego under the Drug Use and Addiction Research Programs (CFDA 93.279) for the period September 1, 2025 through August 31, 2027. This award supports the development and validation of an in vivo massively parallel reporter assay (MPRA) designed to analyze the functional role of cis-regulatory elements and genetic variants associated with substance use...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Pennsylvania a $454,251 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) on July 15, 2025, with a completion date of June 30, 2027. The award supports the development of a novel diagnostic technology for long-term, non-invasive monitoring of opioid-induced changes in neural circuits associated with opioid use disorder (OUD). The research team will develop...
The National Institute on Drug Abuse (NIDA) awarded $185,571 to the University of Pittsburgh under the Drug Use and Addiction Research Programs (CFDA 93.279) on February 15, 2026, for a K01 Mentored Research Scientist Development Award extending through January 31, 2031. Dr. J. Travis Donahoe, a health economist and assistant professor at the University of Pittsburgh School of Public Health, will conduct research advancing science on reducing substance use-related harm through policies and interventions. The award supports Dr. Donahoe's development as an independent investigator through three primary research aims: identifying individual and neighborhood-level factors shaping the fentanyl epidemic using linked survey and vital records data; evaluating the effectiveness of demand- and supply-side policies in reducing overdose deaths among high-risk populations using quasi-experimental methods; and co-developing targeted interventions through human-centered design methods in partnership with community experts in high-risk counties in Pennsylvania and West Virginia. The award includes a structured career development plan encompassing training in social and policy drivers of opioid mortality, population health data and methods, and qualitative and community-engaged intervention development. Dr. Donahoe will receive guidance from a multidisciplinary mentorship team including experts in health care delivery for low-income populations, social epidemiology, qualitative research, social demography, and population health. The deliverables include research outputs from the three research aims, training in interdisciplinary methods and approaches, and evidence-based interventions designed specifically for high-risk populations in the Appalachian region disproportionately affected by the opioid epidemic.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $185.6k | 2/3/26 |